FDA Is Revising Contact-Lens Guidelines To Protect Against Infections
This article was originally published in The Gray Sheet
Executive Summary
The agency’s ophthalmic device advisory panel is meeting in May to address FDA’s plans to revise guidance documents describing 510(k) submissions for contact lenses and lens care products. The changes would incorporate lessons learned since the infectious outbreaks linked to multipurpose contact lens solution in the past decade.